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A network of dendritic 
cells in the kidney
Dendritic cells are the major 
sentinels of the immune systems; in 
non-lymphoid organs they receive 
signals from a variety of sources and 
coordinate the response of the innate 
and adaptive immune systems. Th e 
kidney, like other organs, contains 
dendritic cells, but their distribution 
and location were somewhat obscure. 
As they report in this issue, Soos et al. 
studied mice that express glomerular 
fi ltration rate under the control of the 
promoter of the chemokine receptor 
CX3CR1. Dendritic cells diff erentiate 
from bone marrow monocytes and 
begin to express this receptor; hence 
the distribution of these cells could be 
readily followed in a non-destructive 
manner. Remarkably, dendritic cells in 
the kidney were present in an extensive 
and contiguous network of fl uorescent 
cells throughout the interstitial and 
mesangial spaces of the entire kidney. 
Dendritic cells, as their name suggests, 
are satellite in shape; this characteristic 
shape can be readily observed in the 
kidney. When these cells were isolated, 
they were found to express CD11c 
and F4/80 and a signifi cant amount of 
major histocompatibility complex class 
II and Fc receptors, all characteristic 
of dendritic cells. Th ey were capable 
of phagocytosis. Intravital microscopy 
of the superfi cial cortex showed 
stationary interstitial CX3CR1
+ 
dendritic cells that continually probed 
the surrounding tissue environment 
through dendrite extensions. Hence, 
the kidney contains dendritic cells that 
continually sample the glomerular 
and tubulointerstitial space. Th is 
paper opens the fi eld for study of the 
role of these cells in renal disease. See 
page 591. Th ree fascinating videos 
demonstrating live CX3CR1
+ dendritic 
cells can be found attached to the 
article by Soos et al. on our web site 
(http://www.nature.com/ki/index.
html). You can view the movies by 
accessing the article, then clicking on 
the ‘supplemental info’ link.
Mechanism of uremic 
muscle wasting
Muscle wasting, a major problem in 
patients with chronic kidney disease, 
has many causes, including chronic 
infl ammation, malnutrition, and lack 
of exercise. Resistance to a variety of 
anabolic hormones such as insulin-
like growth factor-1 (IGF-1) and its 
stimulator growth hormone (GH) is 
well documented. As they report in 
this issue, Sun et al. tested whether 
work overload could increase skeletal 
muscle IGF-1 expression, thereby 
bypassing defective GH action. Work 
overload was initiated in pair-fed 
rats with or without renal failure. As 
expected, work overload increased 
muscle weight in both types of animals 
and counteracted the atrophy seen 
in uremia. Administration of GH 
increased expression of IGF-1 in 
rats with normal renal function, but 
uremia attenuated this expression 
signifi cantly. Similarly, work overload 
also caused a higher expression of 
muscle IGF-1 in normal as opposed 
to uremic animals. However, long-
term work overload resulted in an 
equivalent increase in both groups of 
animals. Myostatin, a member of the 
transforming growth factor-β family 
of proteins that is a critical regulator 
of muscle mass, acts as an inhibitor of 
muscle hypertrophy. Th e expression 
of myostatin in the atrophic uremic 
muscle was high but normalized 
aft er work overload, suggesting its 
involvement in the wasting process. 
Th ese results suggest that alterations 
in the balance between IGF-1 and 
myostatin play an important role in 
uremic muscle wasting. See page 453.
Heme oxygenase-1 
in renal health and 
disease
Th e identifi cation of the presence 
of carbon monoxide gas (CO) in 
biological tissues came as a great 
surprise, and the fi nding that it was 
a ‘benefi cial’ agent in the response 
to injury could only be described 
as bizarre. Heme oxygenase is an 
enzyme that produces CO during the 
degradation of heme to biliverdin, 
during which iron is also released. 
One of two heme oxygenases, HO-1, is 
induced in the kidney in response to a 
variety of injuries, including ischemia, 
nephrotoxins, cytokines, endotoxin, 
oxidants, and vasoactive substances. 
Genetic defi ciency of HO-1 results 
in hemolytic anemia, endothelial 
injury, iron deposition, and mesangial 
proliferation. CO, a well-known 
poison, is actually cytoprotective in 
very low concentrations and acts as a 
vasodilator. Bile pigments, the by-
products of HO-1, are antioxidants, 
the present-day magic bullets for all 
diseases. In a review article, Nath 
reviews this fascinating subject and 
sets it in the context of normal kidneys 
as well as renal injury and disease. 
He provides a valuable analysis of the 
conditions that cause overexpression 
of HO-1 in the kidney and in other 
tissues as well. See page 432.
